Newsroom
|
|
Newsroom |
|
 |
|
|
|
|
|
|
|
|
|
|
|||||
|
Newsroom Latest Press Releases
Follow Us!
Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX One in Six Pregnant Women Tested Are Positive for Hypothyroidism
Quest Diagnostics Health Trends™ study of half a million pregnant women in the United States finds 15.5% of those tested were positive for gestational hypothyroidism, much higher than prior estimates. Learn more. One in Three First-Time Participants in Laboratory-Based Wellness Program Learn of High Risk for Chronic Disease, Quest Diagnostics Study Shows
Eighty-nine percent of those at high risk for chronic kidney disease, 59 Percent of those at high risk for high cholesterol, and 28 percent of those at high risk for diabetes first learned of health condition through lab-based wellness program. For more information, click here. Quest Diagnostics Encourages Participation in Historic American Cancer Society Prevention Study
Quest Diagnostics, the American Cancer Society, and NBA Denver Nuggets coach George Karl joined to encourage Denver-area residents to participate in the American Cancer Society's historic Cancer Prevention Study - 3 (CPS-3). The CPS-3 Study focuses on uncovering the lifestyle, environmental and genetic factors that influence cancer risk by following 300,000 adults over the course of 20 years. To learn more, click here. Quest Diagnostics Drug Testing Index™ Reports Hydrocodone and Oxycodones Lead U.S. General Workforce Positives
Hydrocodone and oxycodones remained the most detected prescription opiates in the U.S. general workforce, with 1.3% and 1.1% positivity rates, respectively, in the first half of 2011. Compared to 2005 levels, oxycodones are 96% higher and hydrocodone 47% higher in positive prevalence. Learn more. Quest Diagnostics selected as member of Dow Jones® Sustainability Index
Quest Diagnostics today announced that it has again been selected to be part of the Dow Jones® Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). For more, click here. U.S. Workforce’s Challenge with Methamphetamine Featured in Quest Diagnostics Drug Testing Index™
New data published shows regional and state trends regarding methamphetamine positivity in workplace drug testing. Learn more. Colon Cancer Testing Advances
ColoVantage is the first blood-based test available in the United States for aiding the detection of colon cancer in patients who avoid or are unable to undergo a colonoscopy or other established testing method. A national poll by the Colon Cancer Alliance and Quest Diagnostics finds that about one in three people 50 years of age or older say they haven’t been screened for colon cancer. Quest Diagnostics Health Trends — Allergies Across America
Learn why allergies may be on the rise: Read Allergies Across America, the largest study ever conducted on allergy testing. |
